drugset / Trial / NCT00688558
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate safety of JTT-705 and to demonstrate efficacy of JTT-705 compared with placebo when co-administered with simvastatin 40 mg in patients with low HDL
Timeline
- Start
- 2004-02
- Primary completion
- 2004-12
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalcetrapib | Small molecule | 600 mg | Oral |
| Background | Simvastatin | Small molecule | 40 mg | Oral |